601.66MMarket Cap-2622P/E (TTM)
2.560High2.335Low499.49KVolume2.530Open2.590Pre Close1.20MTurnover0.30%Turnover RatioLossP/E (Static)254.94MShares3.41052wk High1.00P/B387.55MFloat Cap1.32052wk Low--Dividend TTM164.22MShs Float19.840Historical High--Div YieldTTM8.69%Amplitude1.320Historical Low2.392Avg Price1Lot Size
Lyell Immunopharma Stock Forum
Select biotech/pharma names showing strength following ESMO:
$Clovis Oncology(CLVS.US)$ +11.3%, $Cardiff Oncology(CRDF.US)$ +9%, $Immatics(IMTX.US)$ +8.3%, $IDEAYA Biosciences(IDYA.US)$ +8%, $Lyra Therapeutics(LYRA.US)$ +5.7%, $POINT Biopharma(PNT.US)$ +5.7%, $Edgewise Therapeutics(EWTX.US)$ +4.7%, $Concert Pharmaceuticals(CNCE.US)$ +3.6%, $Deciphera Pharmaceuticals(DCPH.US)$ +3.2%, $Veracyte(VCYT.US)$ +2.6%, $SpringWorks Therapeutics(SWTX.US)$ +2.3%, ...
No comment yet